J. Anthony Ware

J. Anthony Ware discloses dealings in 2 companies, chiefly Anaptysbio, Inc and First Tracks Biotherapeutics, Inc. Over a trading history stretching from 10 December 2019 to 2 September 2026, the count stands at 6 filings.

Market trades split into 1 purchase (€46k) and 2 sales (€1.7M). Netting one side against the other leaves €1.6M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

The latest filing, published on 4 September 2026, reports an option exercise of €195k in First Tracks Biotherapeutics, Inc. The clock since the last published purchase (6 February 2020) now reads 2,467 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.